Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancerGiampietro Gasparini, Dino Amadori, Massimo Gion et al.|Breast Cancer Research and Treatment|2006Cited by 140
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinomaEmilio Bajetta, Roberto Buzzoni, Salvatore Artale et al.|Cancer|2004Cited by 135